CEAPRO INC. ("CZO")
BULLETIN TYPE: Plan of Arrangement, Remain Halted, Delist
BULLETIN DATE: June 4, 2024
TSX Venture Tier 2 Company
TSX Venture Exchange (the "Exchange") has accepted for filing documentation in connection with an arrangement agreement dated December 14, 2023, as amended on January 16, 2024, between Ceapro Inc. ("Ceapro") and Aeterna Zentaris Inc. ("Aeterna"), pursuant to which Aeterna acquired all of the issued and outstanding common shares of Ceapro by way of a plan of arrangement under the Canada Business Corporations Act (the "Arrangement"). Under the terms of the Arrangement, Ceapro shareholders received 0.02360 of an Aeterna share for each Ceapro share held. The transaction also provided that all outstanding options of Ceapro were exchanged into securities of Aeterna in accordance with the terms of the Arrangement.
The Exchange has been advised that the requisite approval of the Arrangement by Ceapro shareholders was received at a special meeting of shareholders held on March 12, 2024, and that the Court of King's Bench of Alberta granted a final order with respect to the Arrangement on March 28, 2024. The Arrangement was completed on June 3, 2024.
Delisting:
Effective at the close of business on Thursday, June 6, 2024, the common shares of Ceapro will be delisted from the TSX Venture Exchange.
For further details, please refer to management information circulars dated March 12, 2024, and filed by Aeterna and Ceapro which are available under each company's profile on SEDAR+, and Ceapro's news releases dated December 14, 2023, February 15, 2024, February 23, 2024, February 26, 2024, March 12, 2024, March 28, 2024, May 17, 2024, and June 3, 2024.